Examining the same MLL probe sets as above, we observed a decrease in MLL expression in T-ALL relapse specimens vs. diagnosis specimens (Figure 2B) comparable to that measurable in GC resistant vs. sensitive specimens [17] (Figure 2A). This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.